De Novo Urothelial Carcinoma in Kidney Transplant Patients With End-Stage Aristolochic Acid Nephropathy in China

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1619-1623

  Yuan, M ^a   Shi, Y B ^a   Li, Z H ^b   Xia, M ^b   Ji, G Z ^b   Xu, G X ^a   Han, Y ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTOLOCHIC ACID; AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ACUTE GRAFT REJECTION; ADULT; AGED; ARISTOLOCHIC ACID NEPHROPATHY; ARTICLE; BLADDER; CADAVER KIDNEY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CARCINOMA; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; NEPHRECTOMY; PELVIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRADITIONAL MEDICINE; TREATMENT OUTCOME; URETER; URINARY TRACT; UROTHELIUM; UROTHELIUM CARCINOMA;

ADULT; AGED; ANTIVIRAL AGENTS; ARISTOLOCHIC ACIDS; CADAVER; CARCINOMA, TRANSITIONAL CELL; CHINA; FEMALE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DONORS; UROLOGIC NEOPLASMS;

EID: 67249110457     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.01.081     Document Type: Article

References (20)

1. Vanherweghem J.L., Depierreux M., Tielemans C., et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341 (1993) 387
2. Chang C.H., Wang Y.M., Yang A.H., et al. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol 21 (2001) 441
3. Debelle F.D., Vanherweghem J.L., and Nortier J.L. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 74 (2008) 158
4. Cosyns J.P., Jadoul M., Squifflet J.P., et al. Urothelial malignancy in nephropathy due to Chinese herbs. Lancet 344 (1994) 188
5. Cosyns J.P., Jadoul M., Squifflet J.P., et al. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 33 (1999) 1011
6. Nortier J.I., Martinez M.C., Schmeiser H.H., et al. Urothelial carcinoma associated with the use of Chinese herb (Aristolochia fangchi). N Engl J Med 342 (2000) 1686
7. Lord G.M., Cook T., Arlt V.M., et al. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 358 (2001) 1515
8. Nortier J.L., Schmeiser H.H., Martinez M.C., et al. Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol Dial Transplant 18 (2003) 426
9. Li W.H., Yang L., Su T., et al. Influence of taking aristolochic acid-containing Chinese drugs on occurrence of urinary transitional cell caner in uremic patients undergoing dialysis. Zhonghua Yi Xue Za Zhi 85 (2005) 2487
10. Stiborová M., Sopko B., Hodek P., et al. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen. Cancer Lett 229 (2005) 193
11. Arlt V.M., Alunni-Perret V., Quatrehomme G., et al. Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer. Int J Cancer 111 (2004) 977
12. Penn I. Malignancies associated with renal transplantation. Urology 10 (1977) 57
13. Sheil A.G., Disney A.P., Mathew T.H., et al. Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. Transplant Proc 29 (1997) 825
14. Birkeland S.A., Storm H.H., and Lamm L.U. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 60 (1995) 183
15. Yang T.C., Shu K.H., Chen C.H., et al. Malignancy following renal transplantation. Zhonghua Yi Xue Za Zhi (Taipei) 61 (1998) 281
16. Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther 7 (2000) 147
17. Li X.B., Xing N.Z., Wang Y., et al. Transitional cell carcinoma in renal transplant recipients: a single center experience. Int J Urol 15 (2008) 53
18. Debelle F.D., Nortier J.L., De Prez E.G., et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol 13 (2002) 431
19. Arlt V.M., Wiessler M., and Schmeiser H.H. Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene. Carcinogenesis 21 (2000) 235
20. Peng M.Q., Yang Z.H., and Fang Z.L. An assemble analysis of malignancy following renal transplantation in China. Chin J Organ Transplant 26 (2005) 269